Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Imprimir: 0893-9675
ISSN On-line: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.2016016084
pages 115-124

Gene Therapy for Lung Cancer

Humberto Lara-Guerra
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
Jack A. Roth
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

RESUMO

Gene therapy was originally conceived to treat monogenic diseases. The replacement of a defective gene with a functional gene can theoretically cure the disease. In cancer, multiple genetic defects are present and the molecular profile changes during the course of the disease, making the replacement of all defective genes impossible. To overcome these difficulties, various gene therapy strategies have been adopted, including immune stimulation, transfer of suicide genes, inhibition of driver oncogenes, replacement of tumor-suppressor genes that could mediate apoptosis or anti-angiogenesis, and transfer of genes that enhance conventional treatments such as radiotherapy and chemotherapy. Some of these strategies have been tested successfully in non-small-cell lung cancer patients and the results of laboratory studies and clinical trials are reviewed herein.

Palavras-chave: lung cancer, gene therapy

Articles with similar content:

Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy
Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 2
Atul K. Tiwari, Naveen K. Vishvakarma, Dhananjay Shukla, Sapnita Shinde, Saurabh Saxena, Vineeta Dixit
Cancer Stem Cells in Urooncology
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 1
Cag Cal, Zeynep Yuce
Emerging Immunotherapies for Cancer and Their Potential for Application in Pediatric Oncology
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 3-4
Crystal L. Mackall, Rimas J. Orentas
Polymeric Immunonanoparticles Mediated Cancer Therapy: Versatile Nanocarriers for Cell-Specific Cargo Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 1
Niyati S. Acharya, Namdev L. Dhas, Ritu R. Kudarha, Sanjeev R. Acharya
Treating Colorectal Cancer with Western and Chinese Medicine
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 4
C. Junghanss, M. Leithauser, Hans Lampe, M. Freund